NK1 antagonists
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Rao Ashwin U Paliwal Sunil Shah Sapna S Palani Anandan Wrobleski Michelle Laci Xiao Dong Tsui Hon-Chung Huang Xianhai Shih Neng-Yang Wang Cheng |
| description | A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9469629B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9469629B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9469629B23</originalsourceid><addsrcrecordid>eNrjZOD38zZUSMwrSUzPz8ssLinmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWJmaWZkaWTkbGRCgBAC_5Hnc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NK1 antagonists</title><source>esp@cenet</source><creator>Rao Ashwin U ; Paliwal Sunil ; Shah Sapna S ; Palani Anandan ; Wrobleski Michelle Laci ; Xiao Dong ; Tsui Hon-Chung ; Huang Xianhai ; Shih Neng-Yang ; Wang Cheng</creator><creatorcontrib>Rao Ashwin U ; Paliwal Sunil ; Shah Sapna S ; Palani Anandan ; Wrobleski Michelle Laci ; Xiao Dong ; Tsui Hon-Chung ; Huang Xianhai ; Shih Neng-Yang ; Wang Cheng</creatorcontrib><description>A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161018&DB=EPODOC&CC=US&NR=9469629B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161018&DB=EPODOC&CC=US&NR=9469629B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Rao Ashwin U</creatorcontrib><creatorcontrib>Paliwal Sunil</creatorcontrib><creatorcontrib>Shah Sapna S</creatorcontrib><creatorcontrib>Palani Anandan</creatorcontrib><creatorcontrib>Wrobleski Michelle Laci</creatorcontrib><creatorcontrib>Xiao Dong</creatorcontrib><creatorcontrib>Tsui Hon-Chung</creatorcontrib><creatorcontrib>Huang Xianhai</creatorcontrib><creatorcontrib>Shih Neng-Yang</creatorcontrib><creatorcontrib>Wang Cheng</creatorcontrib><title>NK1 antagonists</title><description>A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOD38zZUSMwrSUzPz8ssLinmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWJmaWZkaWTkbGRCgBAC_5Hnc</recordid><startdate>20161018</startdate><enddate>20161018</enddate><creator>Rao Ashwin U</creator><creator>Paliwal Sunil</creator><creator>Shah Sapna S</creator><creator>Palani Anandan</creator><creator>Wrobleski Michelle Laci</creator><creator>Xiao Dong</creator><creator>Tsui Hon-Chung</creator><creator>Huang Xianhai</creator><creator>Shih Neng-Yang</creator><creator>Wang Cheng</creator><scope>EVB</scope></search><sort><creationdate>20161018</creationdate><title>NK1 antagonists</title><author>Rao Ashwin U ; Paliwal Sunil ; Shah Sapna S ; Palani Anandan ; Wrobleski Michelle Laci ; Xiao Dong ; Tsui Hon-Chung ; Huang Xianhai ; Shih Neng-Yang ; Wang Cheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9469629B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Rao Ashwin U</creatorcontrib><creatorcontrib>Paliwal Sunil</creatorcontrib><creatorcontrib>Shah Sapna S</creatorcontrib><creatorcontrib>Palani Anandan</creatorcontrib><creatorcontrib>Wrobleski Michelle Laci</creatorcontrib><creatorcontrib>Xiao Dong</creatorcontrib><creatorcontrib>Tsui Hon-Chung</creatorcontrib><creatorcontrib>Huang Xianhai</creatorcontrib><creatorcontrib>Shih Neng-Yang</creatorcontrib><creatorcontrib>Wang Cheng</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Rao Ashwin U</au><au>Paliwal Sunil</au><au>Shah Sapna S</au><au>Palani Anandan</au><au>Wrobleski Michelle Laci</au><au>Xiao Dong</au><au>Tsui Hon-Chung</au><au>Huang Xianhai</au><au>Shih Neng-Yang</au><au>Wang Cheng</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NK1 antagonists</title><date>2016-10-18</date><risdate>2016</risdate><abstract>A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US9469629B2 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | NK1 antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A16%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Rao%20Ashwin%20U&rft.date=2016-10-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9469629B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |